Skip to Main Content

Author Details

Naoto Kondo
Nagoya City University Graduate School of Medical Sciences
2006
62
17
PMIDPaper TitleJournal TitlePublished Year
36229542Low TINAGL1 expression is a marker for poor prognosis in breast cancer.J Cancer Res Clin Oncol2023
37804479The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition.Breast Cancer2023
37518190ASO Visual Abstract: Long-Term Outcomes of Breast Cancer Patients with Local Recurrence After Mastectomy Undergoing Immediate Breast Reconstruction-A Retrospective, Multi-institutional Study of 4153 Cases.Ann Surg Oncol2023
37688665Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer.Breast Cancer Res Treat2023
37454021ASO Author Reflections: Long Term Outcomes of Breast Cancer Patients with Local Recurrence After Mastectomy Undergoing Immediate Breast Reconstruction.Ann Surg Oncol2023
37405666Long-Term Outcomes of Breast Cancer Patients with Local Recurrence After Mastectomy Undergoing Immediate Breast Reconstruction: A Retrospective Multi-institutional Study of 4153 Cases.Ann Surg Oncol2023
37069366Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry.Breast Cancer2023
36527601Physicians' perception about the impact of breast reconstruction on patient prognosis: a survey in Japan.Breast Cancer2023
36371582Classification of Local Recurrence After Nipple-Sparing Mastectomy Based on Location: The Features of Nipple-Areolar Recurrence Differ from Those of Other Local Recurrences.Ann Surg Oncol2023
34992692Discovering novel mechanisms of taxane resistance in human breast cancer by whole-exome sequencing.Oncol Lett2022
35530276Low HECTD1 mRNA expression is associated with poor prognosis and may be correlated with increased mitochondrial respiratory function in breast cancer.Am J Cancer Res2022
35941421Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: a multi-center prospective observational study.Breast Cancer Res Treat2022
36192404Co-expression effect of LLGL2 and SLC7A5 to predict prognosis in ERα-positive breast cancer.Sci Rep2022
35980544Granulocyte colony-stimulating factor-associated aortitis in a woman with breast cancer: a case report.Surg Case Rep2022
32715420Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study.Breast Cancer2021
33782811Low RAI2 expression is a marker of poor prognosis in breast cancer.Breast Cancer Res Treat2021
33886078Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.Breast Cancer2021
34554370A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17).Breast Cancer Res Treat2021
33987233Oral care and oral assessment guide in breast cancer patients receiving everolimus and exemestane: subanalysis of a randomized controlled trial (Oral Care-BC).Ann Transl Med2021
34292500Predictive factors for patients who need treatment for chronic post-surgical pain (CPSP) after breast cancer surgery.Breast Cancer2021
33321004Current Status of Advance Care Planning and End-of-life Communication for Patients with Advanced and Metastatic Breast Cancer.Oncologist2021
33413212Secondary endpoints analysis in patients with estrogen receptor-positive metastatic breast cancer treated with everolimus and exemestane enrolled in Oral Care-BC.BMC Cancer2021
32240526The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.Breast Cancer2020
32079618Recounting the FANTOM CAGE-Associated Transcriptome.Genome Res2020
31723078Digital Mammographic Features of Breast Cancer Recurrences and Benign Lesions Mimicking Malignancy Following Breast-Conserving Surgery and Radiation Therapy.Kurume Med J2020
32043762Oral Care Evaluation to Prevent Oral Mucositis in Estrogen Receptor-Positive Metastatic Breast Cancer Patients Treated with Everolimus (Oral Care-BC): A Randomized Controlled Phase III Trial.Oncologist2020
32856072Sentinel lymph node biopsy may be unnecessary for ductal carcinoma in situ of the breast that is small and diagnosed by preoperative biopsy.Jpn J Clin Oncol2020
32783311The standard form of CD44 as a marker for invasion of encapsulated papillary carcinoma of the breast.Pathol Int2020
30395264Effects of serum estradiol and progesterone on estrogen-regulated gene expression in breast cancers of premenopausal patients.Jpn J Clin Oncol2019
30806921The utility of DHL-HisZnNa, a novel antioxidant, against anticancer agent-induced alopecia in breast cancer patients: a multicenter phase II clinical trial.Breast Cancer Res Treat2019
30946557Specific Features of Fibrotic Lung Fibroblasts Highly Sensitive to Fibrotic Processes Mediated via TGF-β-ERK5 Interaction.Cell Physiol Biochem2019
30855679Prognostic impact of TP53INP1 gene expression in estrogen receptor α-positive breast cancer patients.Jpn J Clin Oncol2019
30793156Smartphone problem-solving therapy to reduce fear of cancer recurrence among breast cancer survivors: an open single-arm pilot study.Jpn J Clin Oncol2019
29027049Acute phase dynamics of circulating tumor cells after paclitaxel and doxorubicin chemotherapy in breast cancer mouse models.Breast Cancer Res Treat2018
30158412[A Phase I Combination Dose-Escalation Study of Eribulin Mesylate and Gemcitabine in Japanese Patients with Metastatic Breast Cancer].Gan To Kagaku Ryoho2018
29494619Shared activity patterns arising at genetic susceptibility loci reveal underlying genomic and cellular architecture of human disease.PLoS Comput Biol2018
28850106FANTOM5 CAGE profiles of human and mouse samples.Sci Data2017
29079795Comprehensive single-cell transcriptome analysis reveals heterogeneity in endometrioid adenocarcinoma tissues.Sci Rep2017
27015895Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.BMC Cancer2016
26482374Prognostic impact of a single-nucleotide polymorphism near the CTSO gene in hormone receptor-positive breast cancer patients.Int J Clin Oncol2016
26642960HER2 mutation status in Japanese HER2-positive breast cancer patients.Breast Cancer2016
25528021Prognostic factors of HER2-positive breast cancer patients who develop brain metastasis: a multicenter retrospective analysis.Breast Cancer Res Treat2015
25964183Efficient capturing of circulating tumor cells using a magnetic capture column and a size-selective filter.Bioprocess Biosyst Eng2015
25678556Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells.Science2015
23007312Feasibility of intraoperative radiation therapy for early breast cancer in Japan: a single-center pilot study and literature review.Breast Cancer2014
25202396Impact of intrinsic subtype on predicting axillary lymph node metastasis in breast cancer.Oncol Lett2014
25106661Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis.Breast Cancer Res Treat2014
24548884FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.Br J Cancer2014
24523941Development of a new rapid isolation device for circulating tumor cells (CTCs) using 3D palladium filter and its application for genetic analysis.PLoS One2014
24670763An atlas of active enhancers across human cell types and tissues.Nature2014
  • 1 - 50 of 62

Recommended Authors

Kevin Punie
Leuven Cancer Institute and University Hospitals Leuven
Career Start Year 2015
Number of shared co-authors 19
Konstantinos Tryfonidis
Merck & Co., Inc.
Career Start Year 2011
Number of shared co-authors 2
Yin Liu
Fudan University Shanghai Cancer Center
Career Start Year 2011
Number of shared co-authors 0
Xiangnan Kong
Qilu Hospital of Shandong University
Career Start Year 2011
Number of shared co-authors 0
Carmen Criscitiello
University of Milano
Career Start Year 2008
Number of shared co-authors 0
Yin Guan
DHC Technologies Co. Ltd.
Career Start Year 2008
Number of shared co-authors 0
Bora Lim
The University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 0
Catherine M Kelly
Mater Misericordiae University Hospital
Career Start Year 2006
Number of shared co-authors 0
Christina Yau
University of California San Francisco
Career Start Year 2005
Number of shared co-authors 3
Aditya Bardia
Massachusetts General Hospital Cancer Center
Career Start Year 2004
Number of shared co-authors 3
Jeong Eon Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
David W Cescon
Princess Margaret Cancer Centre
Career Start Year 2003
Number of shared co-authors 0
Matthew P Goetz
Mayo Clinic
Career Start Year 2002
Number of shared co-authors 6
Nicola Fusco
IEO European Institute of Oncology IRCCS
Career Start Year 2002
Number of shared co-authors 0
Wei Zhang
Children's Hospital, Zhejiang University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Fatima Cardoso
Champalimaud Clinical Center/Champalimaud Foundation
Career Start Year 2000
Number of shared co-authors 2
Ingrid A Mayer
Vanderbilt University Medical Center
Career Start Year 2000
Number of shared co-authors 3
Jeong-Won Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1999
Number of shared co-authors 24
Massimo Cristofanilli
Weill Cornell School of Medicine
Career Start Year 1998
Number of shared co-authors 1
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Giuseppe Curigliano
University of Milan
Career Start Year 1996
Number of shared co-authors 2
Steven J Isakoff
Massachusetts General Hospital
Career Start Year 1995
Number of shared co-authors 1
Naoto T Ueno
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Career Start Year 1995
Number of shared co-authors 2
Daniel Rea
Institute of Cancer and Genomic Sciences, The University of Birmingham
Career Start Year 1993
Number of shared co-authors 2
Kelly K Hunt
The University of Texas MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 0
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 3
Joan Albanell
Hospital del Mar Research Institute
Career Start Year 1990
Number of shared co-authors 1
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 30
Alberto Zambelli
IRCCS Humanitas Research Hospital
Career Start Year 1987
Number of shared co-authors 8
Eric P Winer
Dana-Farber Cancer Institute
Career Start Year 1985
Number of shared co-authors 2

Collaborators

Piero Carninci
RIKEN Center for Integrative Medical Sciences
Co-authored papers 6
Masayoshi Itoh
RIKEN Center for Integrative Medical Sciences
Co-authored papers 6
Harukazu Suzuki
RIKEN Center for Integrative Medical Sciences
Co-authored papers 6
Carsten O Daub
International Institute of Molecular and Cell Biology in Warsaw
Co-authored papers 5
Yoshihide Hayashizaki
Center for Integrative Medical Sciences
Co-authored papers 5
Jun Kawai
RIKEN Center for Integrative Medical Sciences
Co-authored papers 5
John Kenneth Baillie
Roslin Institute, University of Edinburgh
Co-authored papers 5
Timo Lassmann
Telethon Kids Institute, University of Western Australia
Co-authored papers 5
David A Hume
Mater Research Institute-UQ, Translational Research Institute
Co-authored papers 5
Alistair R R Forrest
RIKEN Center for Integrative Medical Sciences
Co-authored papers 5
Hideya Kawaji
RIKEN Center for Integrative Medical Sciences
Co-authored papers 5
Robin Andersson
University of Copenhagen
Co-authored papers 4
Erik Arner
RIKEN Center for Integrative Medical Sciences (IMS)
Co-authored papers 4
Michael Rehli
University Hospital Regensburg
Co-authored papers 4
Christine A Wells
The University of Melbourne
Co-authored papers 4
Takeya Kasukawa
RIKEN Center for Integrative Medical Sciences
Co-authored papers 4
Albin Sandelin
University of Copenhagen
Co-authored papers 4
Marina Lizio
Cerevance Ltd
Co-authored papers 4
Geoffrey J Faulkner
Mater Research Institute - University of Queensland
Co-authored papers 4
Yuri Ishizu
RIKEN Center for Life Science Technologies
Co-authored papers 4
Andreas Lennartsson
Karolinska Institute
Co-authored papers 4
Peter Heutink
German Center for Neurodegenerative Diseases (DZNE).
Co-authored papers 4
Berit Lilje
Statens Serum Institut
Co-authored papers 3
Haruhiko Koseki
RIKEN Research Center for Allergy and Immunology
Co-authored papers 3
Yosuke Mizuno
Yokohama National University
Co-authored papers 3
Reto Guler
International Centre for Genetic Engineering and Biotechnology
Co-authored papers 3
Ernst J Wolvetang
Australian Institute for Bioengineering and Nanotechnology, University of Queensland
Co-authored papers 3
Suzana Savvi
South African Medical Research Council (SAMRC), University of Cape Town
Co-authored papers 3
Soichi Ogishima
Tohoku University Graduate School of Medicine
Co-authored papers 3
Christine L Mummery
Leiden University Medical Center
Co-authored papers 3
Release 1.2